{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:44:56Z","timestamp":1790225096158,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"South Africa Medical Research Council"},{"DOI":"10.13039\/501100001321","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001325","name":"Cancer Association of South Africa (CANSA)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ligue Nationale Contre le Cancer et comit\u00e9 de l'Oise"},{"DOI":"10.13039\/501100002824","name":"INCa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002824","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pair Melanoma"},{"name":"Canc\u00e9ropole IdF"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.canlet.2017.07.018","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T03:31:58Z","timestamp":1501212718000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor"],"prefix":"10.1016","volume":"405","author":[{"given":"Jade","family":"Peres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza M.","family":"Kwesi-Maliepaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Rambow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2010-6107","authenticated-orcid":false,"given":"Lionel","family":"Larue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2017.07.018_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.det.2012.04.006","article-title":"New approaches to melanoma prevention","volume":"30","author":"Robinson","year":"2012","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.canlet.2017.07.018_bib2","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/515S110a","article-title":"The cancer that rises with the Sun","volume":"515","author":"Holmes","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2017.07.018_bib3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1586\/era.10.170","article-title":"A\u00a0new understanding in the epidemiology of melanoma","volume":"10","author":"Erdei","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.canlet.2017.07.018_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1758834015616934","article-title":"Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy","volume":"8","author":"Eroglu","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.canlet.2017.07.018_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/1947601910365160","article-title":"The highly homologous t-box transcription factors, TBX2 and TBX3, have distinct roles in the oncogenic process","volume":"1","author":"Peres","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.canlet.2017.07.018_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1476-4598-12-117","article-title":"The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion","volume":"12","author":"Peres","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2017.07.018_bib7","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-04-0731","article-title":"Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas","volume":"64","author":"Hoek","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.07.018_bib8","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-08-0301","article-title":"Tbx3 represses E-cadherin expression and enhances melanoma invasiveness","volume":"68","author":"Rodriguez","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.07.018_bib9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/jid.2012.421","article-title":"Oncogenic B-RAF V600E signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion","volume":"133","author":"Boyd","year":"2013","journal-title":"J.\u00a0Investig. Dermatol."},{"key":"10.1016\/j.canlet.2017.07.018_bib10","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.18632\/oncotarget.2782","article-title":"The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis","volume":"6","author":"Peres","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2017.07.018_bib11","first-page":"380","article-title":"T-box transcription factors in cancer biology","volume":"1846","author":"Wansleben","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2017.07.018_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2017.07.018_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.semcancer.2012.07.003","article-title":"A\u00a0comparison of epithelial-to-mesenchymal transition and re-epithelialization","volume":"22","author":"Leopold","year":"2012","journal-title":"Seminars Cancer Biol."},{"key":"10.1016\/j.canlet.2017.07.018_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bbadis.2011.02.002","article-title":"MicroRNAs and the cell cycle","volume":"1812","author":"Bueno","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Basis Dis."},{"key":"10.1016\/j.canlet.2017.07.018_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2017.07.018_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.canlet.2017.07.018_bib17","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1172\/JCI32577","article-title":"Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications","volume":"117","author":"Calin","year":"2007","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.canlet.2017.07.018_bib18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","article-title":"MicroRNA and cancer","volume":"6","author":"Jansson","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2017.07.018_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd3179","article-title":"Targeting microRNAs in cancer: rationale, strategies and challenges, nature reviews","volume":"9","author":"Garzon","year":"2010","journal-title":"Drug Discov."},{"key":"10.1016\/j.canlet.2017.07.018_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/pcmr.12346","article-title":"MicroRNAs in melanocyte and melanoma biology","volume":"28","author":"Mione","year":"2015","journal-title":"Pigment. Cell Melanoma Res."},{"key":"10.1016\/j.canlet.2017.07.018_bib21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/jid.2012.357","article-title":"miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes","volume":"133","author":"Luo","year":"2013","journal-title":"J.\u00a0Investig. Dermatol."},{"key":"10.1016\/j.canlet.2017.07.018_bib22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.2011.568","article-title":"Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors","volume":"106","author":"Xu","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2017.07.018_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1152\/physiolgenomics.00116.2013","article-title":"miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma","volume":"45","author":"Bennett","year":"2013","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.canlet.2017.07.018_bib24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.celrep.2015.09.037","article-title":"New functional signatures for understanding melanoma biology from tumor cell lineage-specific analysis","volume":"13","author":"Rambow","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2017.07.018_bib25","first-page":"140","article-title":"Low expression of Mir-137 predicts poor prognosis in cutaneous melanoma patients","volume":"22","author":"Li","year":"2016","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.canlet.2017.07.018_bib26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/0008-5472.CAN-07-2912","article-title":"MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines","volume":"68","author":"Bemis","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.07.018_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7150\/ijbs.7.133","article-title":"MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines","volume":"7","author":"Deng","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2017.07.018_bib28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/exd.12812","article-title":"miR-137 inhibits proliferation of melanoma cells by targeting PAK2","volume":"24","author":"Hao","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.canlet.2017.07.018_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbrc.2016.05.090","article-title":"miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A","volume":"475","author":"Chang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2017.07.018_bib30","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.scr.2013.09.001","article-title":"MicroRNA-137 represses Klf4 and Tbx3 during differentiation of mouse embryonic stem cells","volume":"11","author":"Jiang","year":"2013","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.canlet.2017.07.018_bib31","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1038\/sj.onc.1210546","article-title":"Activation of NF-\u03baB by Akt upregulates Snail expression and induces epithelium mesenchyme transition","volume":"26","author":"Julien","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2017.07.018_bib32","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1080\/15384101.2015.1080398","article-title":"The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2","volume":"14","author":"Willmer","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2017.07.018_bib33","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1074\/jbc.M705651200","article-title":"UV-mediated regulation of the anti-senescence factor Tbx2","volume":"283","author":"Abrahams","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2017.07.018_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.365","article-title":"A\u00a0novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance","volume":"4","author":"Wansleben","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2017.07.018_bib35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.canlet.2017.07.018_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2017.07.018_bib37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bcp.2010.04.029","article-title":"Targeting the MAPK Pathway in Melanoma: why some approaches succeed and other fail","volume":"80","author":"Inamdar","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2017.07.018_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34-a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.canlet.2017.07.018_bib39","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-10-2010","article-title":"The promise of microRNA replacement therapy,","volume":"70","author":"Bader","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2017.07.018_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.canlet.2017.07.018_bib41","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.canlet.2017.07.018_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s13577-015-0124-4","article-title":"miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1","volume":"29","author":"Han","year":"2016","journal-title":"Hum. Cell"},{"key":"10.1016\/j.canlet.2017.07.018_bib43","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1007\/s13277-014-2177-5","article-title":"miR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor","volume":"35","author":"Liu","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.canlet.2017.07.018_bib44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-016-0415-y","article-title":"MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells","volume":"35","author":"Dong","year":"2016","journal-title":"J.\u00a0Exp. Clin. Cancer Res. CR"},{"issue":"9","key":"10.1016\/j.canlet.2017.07.018_bib45","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2174\/1568009616666160203114140","article-title":"miR-137 suppresses the phosphorylation of AKT and improves the dexamethasone sensitivity in multiple myeloma cells via targeting MITF","volume":"16","author":"Zhang","year":"2016","journal-title":"Curr. Cancer Drug Targets"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517304548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383517304548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T18:20:26Z","timestamp":1656354026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383517304548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":45,"alternative-id":["S0304383517304548"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2017.07.018","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2017.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}